COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00073372
Recruitment Status : Terminated (Based on the data and observed benefit-risk profile, the trial's independent oversight committee recommended that enrollment not resume.)
First Posted : November 21, 2003
Last Update Posted : May 17, 2011
Eli Lilly and Company
Information provided by:
Centocor, Inc.